TNFa-inhibition in the treatment of rheumatoid arthritis

• Other Authors: Moreland, Larry W. (Editor), Emery, Paul (Editor)
• Format: Book
• Language: English
• Published: London New York Independence, KY Martin Dunitz Fulfilment Center, Taylor & Francis 2003
• Subjects: Arthritis, Rheumatoid > drug therapy; Tumor Necrosis Factor Inhibitors; Antibodies, Monoclonal > therapeutic use; Antirheumatic Agents > therapeutic use; Receptors, Tumor Necrosis Factor > therapeutic use
• Online Access: Click Here to View Status and Holdings.
• Physical Description: viii, 180 pages illustrations 21 cm
• Bibliography: Includes bibliographical references and index
• ISBN: 9781841841564; 1841841560

The introduction of tumor-necrosis-factor-alpha (TNFa) blocking agents is one of the milestones in the therapy of rheumatoid arthritis (RA). Edited by Larry Moreland and Paul Emery, experts in rheumatological disease, TNFa-Inhibition in the Treatment of Rheumatoid Arthritis charts the history and development of the concept of TNFa inhibition. The authors document TNFa from its discovery to its now well-documented clinical applications in the treatment of patients with RA. They compare and contrast practical management issues concerning the use of these agents both in the US and UK/Europe. The book is a practical and accessible source containing the most recent information in this field